AGL Earnings & Financial Statements
Agilon Health, Inc.
$87.40
+$1.50(+1.75%)
52
Overall
60
Value
45
Tech
52
Quality
Market Cap
$1.44B
Volume
145.32K
52W Range
$7.48 - $133.04
Target Price
$115.83
AGL earnings and financial statements: Agilon Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
AGL Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $5.93B | $6.06B | $4.32B | $2.39B | $1.83B |
| Cost of revenue | $6.09B | $6.06B | - | $2.28B | - |
| Operating income | -$463.24M | -$292.13M | -$232.13M | -$105.38M | -$393.95M |
| EBITDA | -$368.86M | -$219.25M | -$187.65M | -$72.41M | -$164.81M |
| Net income | -$391.35M | -$260.15M | -$262.60M | -$106.55M | -$406.49M |
| EPS (diluted) | $-0.95 | $-15.75 | $-16.00 | $-6.50 | $-27.25 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B |
| Total liabilities | $1.14B | $1.26B | $1.08B | $656.86M | $494.66M |
| Shareholders’ equity | $126.73M | $470.95M | $661.84M | $1.04B | $1.09B |
| Cash and equivalents | $173.71M | $188.23M | $107.57M | $465.30M | $1.04B |
| Long-term debt | $15.80M | $34.90M | $32.31M | $38.48M | $43.40M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$105.76M | -$57.78M | -$156.20M | -$130.81M | -$148.16M |
| Capital expenditure | -$43.11M | -$41.28M | -$30.82M | -$32.66M | -$13.43M |
| Free cash flow | -$148.87M | -$99.06M | -$187.01M | -$163.47M | -$161.59M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AGL | $87.40 | +1.7% | 145.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |